BACKGROUND. Primary pulmonary osteosarcoma is an extremely rare malignancy.
To date, only 12 cases have been reported, with a high mortality rate. The
authors report on a newly diagnosed patient and describe investigations th
at were performed using immunohistochemistry and comparative genomic hybrid
ization (CGH).
METHODS. The clinical course of a woman age 37 years is presented. Along wi
th routine histologic examination, immunohistochemistry was used to demonst
rate differentiation-associated proteins, oncoproteins, and other markers;
CGH analysis for genomic alterations; and histochemistry to demonstrate alk
aline phosphatase activity.
RESULTS, Immunohistochemical analysis showed Varying expression patterns us
ing antibodies against a panel of tumor markers. Most notable was high over
expression of BCL-2 and cyclin D. CGH analysis showed that this neoplasm co
ntained a much higher level of genetic aberrations compared with skeletal o
steosarcoma.
CONCLUSIONS. This tumor exhibited features common to skeletal osteosarcomas
but also had some unique features. Genome analysis suggests that this tumo
r has several genetic aberrations in common with extraskeletal osteosarcoma
. The novel regions of instability identified within the tumor genome may c
ontribute toward the unique tumor phenotype and relative chemoresistance. (
C) 2001 American Cancer Society.